New knowledge of the biological and clinical importance of the steroid hormone 1␣,25-dihydroxyvitamin D 3 [1␣,25(OH) 2 D 3 ] and its receptor, the vitamin D receptor (VDR), has resulted in significant contributions to good bone health. However, worldwide reports have highlighted a variety of vitamin D insufficiency and deficiency diseases. Despite many publications and scientific meetings reporting advances in vitamin D science, a disturbing realization is growing that the newer scientific and clinical knowledge is not being translated into better human health. Over the past several decades, the biological sphere of influence of vitamin D 3 , as defined by the tissue distribution of the VDR, has broadened at least 9-fold from the target organs required for calcium homeostasis (intestine, bone, kidney, and parathyroid). Now, research has shown that the pluripotent steroid hormone 1␣,25(OH) 2 D 3 initiates the physiologic responses of ͧ36 cell types that possess the VDR. In addition to the kidney's endocrine production of circulating 1␣,25(OH) 2 D 3, researchers have found a paracrine production of this steroid hormone in ͧ10 extrarenal organs. This article identifies the fundamentals of the vitamin D endocrine system, including its potential for contributions to good health in 5 physiologic arenas in which investigators have clearly documented new biological actions of 1␣,25(OH) 2 D 3 through the VDR. As a consequence, the nutritional guidelines for vitamin D 3 intake (defined by serum hydroxyvitamin D 3 concentrations) should be reevaluated, taking into account the contributions to good health that all 36 VDR target organs can provide.
INTRODUCTION
Vitamin D 3 is essential for life in higher animals. Research has shown, for example, that vitamin D 3 is one of the primary biological regulators of calcium homeostasis. Vitamin D 3 's important biological effects occur only as a consequence of its metabolism into a family of daughter metabolites, including the key kidney-produced metabolite 1␣,25-dihydroxyvitamin D 3 [1␣,25(OH) 2 D 3 ]. Researchers consider 1␣,25(OH) 2 D 3 to be a steroid hormone and believe that it functions the same way as other steroid hormones-by interacting with its cognate vitamin D receptor (VDR) (1) .
The role of vitamin D 3 as a vitamin or essential dietary component, in concert with the biological and clinical importance of the steroid hormone 1␣,25(OH) 2 D 3 and the VDR, has achieved increasing prominence over the past 3 to 4 decades in the public health arena because of its contributions to good health in the general public. However, despite the plethora of publications and scientific meetings focusing on advances in vitamin D science, there is the disturbing realization that all is not "well" with the translation of the newer scientific and clinical knowledge into the achievement of better health. Scientists and nutrition experts at the 13th Vitamin D Workshop held in 2006 agreed in a consensus statement that "about half of the elderly in North America and two-thirds of the rest of the world are not getting enough vitamin D to maintain healthy bone density, lower their risks for fractures and improve tooth attachment. Such vitamin D insufficiency also decreases muscle strength and increases the risk for falls and is even associated with increased risk for colorectal and other major cancer" (2) .
The purpose of this article is to identify the fundamentals of the vitamin D endocrine system and the actions of 1␣,25(OH) 2 D 3 that are essential for good health, keeping in mind that the totality of their contributions depends on the adequate availability of 25-hydroxyvitamin D 3 [25(OH)D 3 ], which in turn depends on appropriate vitamin D nutritional status as determined by ultraviolet (UV) radiation exposure and dietary intake of vitamin D 3 .
SOURCES OF VITAMIN D
Vitamin D is not technically a vitamin, ie, it is not an essential dietary factor; rather, it is a prohormone produced photochemically in the skin from 7-dehydrocholesterol. The molecular structure of vitamin D is closely allied to that of classic steroid hormones (eg, estradiol, cortisol, and aldosterone) in that they have the same root cyclopentanoperhydrophenanthrene ring structure. Technically, vitamin D is a secosteroid because one of the rings of its cyclopentanoperhydrophenanthrene structure has a broken carbon-carbon bond; in vitamin D, this occurs in the 9,10 carbon-carbon bond of ring B (Figure 1 ). Given that fact as a starting point, the reader must have access to some of the details of the sunlight-mediated photochemical conversion of 7-dehydrocholesterol into vitamin D 3 ; this information is provided in Figure 1 .
The skin produces vitamin D 3 photochemically from the provitamin D, 7-dehydrocholesterol, which is present in the epidermis or skin of higher animals, by the action of sunlight in most geographical locations or of artificial UV light. The conjugated double-bond system in ring B (see Figure 1 ) allows the absorption of light quanta at certain wavelengths in the UV range, initiating a complex series of transformations of the provitamin (partially summarized in Figure  1 ) that ultimately result in the generation of vitamin D 3 . Thus, vitamin D 3 can be endogenously produced. As long as the animal (or human) has access to adequate sunlight on a regular basis, the animal (or human) might not need to obtain this vitamin from the diet. However, dermatologists are concerned that individuals with extensive UV radiation exposure could have an increased risk of skin cancer or melanoma (3) . A discussion of the parameters affecting the balance between sun exposure and dietary vitamin D to meet bodily requirements is available elsewhere (4) . Because vitamin D 3 is also a vitamin, animals and humans can meet some or all of their vitamin D 3 needs through the diet.
For the past 6 decades, the literature has claimed that vitamin D 3 and vitamin D 2 (see Figure 2 for their structures) have equivalent biological effects in humans. However, with the realization that the serum 25(OH)D clinical assay provides the best assessment of vitamin D nutritional status (5), researchers needed to determine whether vitamin D 2 is as effective in elevating serum 25(OH)D concentrations in humans as is vitamin D 3 . Heaney and others recently confirmed earlier data suggesting that vitamin D 3 is substantially more effective than vitamin D 2 (6, 7) . In a study of 20 healthy human volunteers, these investigators found that vitamin D 2 's potency was less than one-third of vitamin D 3 'spotency on the basis of ability to elevate serum 25(OH)D concentrations. (9) .
VITAMIN D ENDOCRINE SYSTEM
The steps in the vitamin D endocrine system (8) include the following (Figure 3) 3 and its metabolites to their metabolism and target organs (10) .
The most important regulation point in the classic vitamin D endocrine system occurs through the stringent control of the circulating concentration of the steroid hormone 1␣,25(OH) 2 D 3 ; typically, its production is modulated according to the organism's calcium and other endocrine needs. The chief regulatory factors are 1␣,25(OH) 2 D 3 itself, which down-regulates its own production; parathyroid hormone, which stimulates the renal production of 1,25(OH) 2 D 3 ; fetal growth factor 23; and serum concentrations of calcium and phosphate (11) . Probably the most important determinant of the 25(OH)D-1␣-hydroxylase activity is the animal's vitamin D nutritional status (11) . When the circulating concentration of 1␣,25(OH) 2 D 3 is low, production of 1␣,25(OH) 2 D 3 by the kidney is high; when the circulating concentration of 1␣,25(OH) 2 D 3 is high, the output of 1␣,25(OH) 2 D 3 by the kidney decreases sharply (11) .
The pervasive contributions of the VDR in collaboration with its ligand, 1␣,25(OH) 2 D 3, to the functioning of the vitamin D endocrine system are illustrated in Figure 3 and listed in Table 1 . Thirty-six tissues definitively possess the VDR, which means that the cells in these tissues have the potential to produce biological responses, depending on the availability of appropriate amounts of vitamin D 3 . FIGURE 1. Chemistry and irradiation pathway for the production of vitamin D 3 . The provitamin, which is characterized by the presence in the B ring of a ⌬5, ⌬7 conjugated double bond system, is converted to a seco B previtamin steroid after exposure to ultraviolet light and the 9,10 carboncarbon bond is broken. Next, in a process independent of ultraviolet light, the previtamin D thermally isomerizes to the vitamin form, which is characterized by a ⌬6,7, ⌬8,9, ⌬10,19 conjugated triple bond system. The main portion of the figure also illustrates the 2 principal conformations of the molecule that result from rotation about the 6,7 carbon single bond of the seco B ring: the 6-s-cis conformer (the steroid-like shape) and the 6-s-trans conformer (the extended shape). Table 2) . Thus, cells that express a functional 25(OH)D 3 -1␣-hydroxylase acquire the ability to produce local concentrations of the steroid hormone 1␣,25(OH) 2 D 3 . This "local" or modest production of 1␣,25(OH) 2 D 3 then generates biological responses in the local cellular neighborhood. It is believed that this paracrine-generated 1␣,25(OH) 2 D 3 does not normally spill over into the circulatory system; thus, the plasma concentration of 1␣,25(OH) 2 D 3 does not increase in a measurable way. The ability of locally produced 1␣,25(OH) 2 D 3 to promote cell differentiation in prostate cancer (24) and colon cancer cells (25) are examples demonstrating its potential biological importance.
EXPANSION OF VITAMIN D KNOWLEDGE
The consequences that the new knowledge of the vitamin D endocrine system and the various vitamin D metabolites has had on the rate of publication of peer-reviewed articles on vitamin D Table 1 for a list of these target organs. 
1 Based on the presence of the 25-hydroxyvitamin D 3 -1␣-hydroxylase enzyme. Hewison and colleagues have studied the tissue localization of the extrarenal 25-hydroxyvitamin D 3 -1␣-hydroxylase enzyme extensively in humans (18, 20) .
2 Detection of mRNA for the 1␣-hydroxylase and the 1␣-hydroxylase protein.
3 Presence of measurable enzymatic activity of the 25-hydroxyvitamin D 3 -1␣-hydroxylase.
is illustrated in Figure 4 . In 1975, journals published only Ȃ100 articles per year that included the term vitamin D in the title or abstract; by 2007, the rate of publication had increased to 1400 articles per year. Another driving factor for this increased publication rate was the chemical synthesis by academic chemists and by 4 pharmaceutical companies of 2000 analogues of 1␣,25(OH) 2 D; most of these analogues were targeted toward selective responses in diseases such as osteoporosis, renal osteodystrophy, and psoriasis, and the authors reported their biological properties in a multitude of publications (8, 26 Figure 2 emphasizes the structural differences between vitamins D 3 and D 2 and provides a clear description and comparison of the biological properties of these 2 key molecules. This figure shows that 1) vitamin D 3 is the only naturally occurring form of vitamin D in humans and other animals and 2) vitamin D 2 has only one-third the biological activity of vitamin D 3 in humans (7) . Given the significant differences in the biological activity of vitamin D 3 and vitamin D 2, describing a clinical trial by writing that "the patients received 10 g (400 IU) of vitamin D" is not a best practice when the patients actually received vitamin D 2 , whose biological activity is equivalent to only 3.25 g (130 IU) vitamin D 3 .
Another frequent error occurs when authors use vitamin D as a synonym for 1␣,25(OH) 2 D 3 , sometimes even in the methods sections of articles. The very significant structural and biological differences between 1␣,25(OH) 2 D 3 and vitamin D 3 are emphasized in Figure 5 , which clearly shows why authors must not use vitamin D to refer to 1␣,25(OH) 2 D 3 . If, for example, a reader sees the following statement in the results or discussion section of an article, "the animals or subjects received a standard vitamin D dose that would not cause hypercalcemia," he or she would make a serious error of interpretation if he or she had not carefully read the methods section to learn that "all subjects received a dose of 1.5 micrograms of 1␣,25(OH) 2 vitamin D 3. "
MODE OF ACTION OF 1␣,25(OH) 2 D 3 : GENOMIC ACTIONS
The steroid hormone 1␣,25(OH) 2 D 3 and many other steroid hormones (eg, estradiol, progesterone, testosterone, cortisol, and aldosterone) generate biological responses both by regulating gene transcription (the classic genomic responses) and by rapidly activating a variety of signal transduction pathways at or near the plasma membrane (rapid or nongenotropic responses) (27) . The genomic responses to 1␣,25(OH) 2 D 3 result from its stereospecific interaction with its nuclear receptor, VDR nuc (Figure 6 ). The VDR nuc is a protein of 50 kDa, which binds 1␣,25(OH) 2 As is true for all nuclear receptors for the steroid hormones involved, the primary amino acid sequence of the VDR nuc consists of 6 functional domains: the variable regions (A and B domains), DNA binding (the C domain), the hinge region (D domain), the ligand-binding region (E domain), and transcriptional activation (domain F) (28) . A detailed discussion of the VDR nuc and its participation in the regulation of gene transcription is available elsewhere (28) .
Nuclear-receptor-mediated regulation of gene transcription depends on the exquisite structural relation between the unoccupied receptor, which is transcriptionally inactive, and its cognate ligand 1␣,25(OH) 2 D 3 . Formation of the ligand-receptor complex, which results in conformational changes in the receptor protein, then allows the ligand-receptor complex to specifically interact with the many proteins that collectively constitute the transcriptional machinery. The complementarity of the ligand shape with that of the interior surface of the nuclear VDR ligand binding domain is key not only to the structural basis of receptor action and its formation of heterodimers and interactions with coactivators (Figure 7) , but also to designing new drug forms of the various hormones, including 1␣,25(OH) 2 D 3 . Researchers estimate that the VDR can regulate the expression of as many as 500 of the Ȃ20 488 genes in the human genome (29) . The large number of VDR-regulated genes undoubtedly reflects the consequence of the distribution of both the VDR and 25(OH)D 3 -1␣-hydroxylase to many organs.
MODE OF ACTION OF 1␣,25(OH) 2 D 3 : RAPID RESPONSES
Investigators originally postulated that the "rapid" or nongenomic responses mediated by 1␣,25(OH) 2 D 3 were mediated through the interaction of the secosteroid with a novel protein receptor located on the cell's external membrane. Researchers have shown more recently that this membrane receptor is the classic VDR (previously found primarily in the nucleus and cytosol) associated with caveolae present in the plasma membrane of a variety of cells (30) . Caveolae are flask-shaped membrane invaginations enriched in sphingolipids and cholesterol that are commonly found in a wide variety of cells (31) . Using VDR knockout and wild-type mice, researchers found that rapid modulation of osteoblast ion channel responses by 1␣,25(OH) 2 D 3 require the presence of a functional vitamin D nuclear and caveolae VDR receptor (32, 33) .
Careful research using a variety of structural analogues of 1,25(OH) 2 D 3 has shown that the genomic and nongenomic responses to this conformationally flexible steroid hormone have different requirements for ligand structure (34) . For example, a key consideration is the position of rotation about the 6,7 single carboncarbon bond that can be either the 6-s-cis or 6-s-trans orientation (see Figure 1) . The preferred shape of the ligand for VDR nuc , determined from the X-ray crystal structure of the receptor occupied with the ligand 1␣,25(OH) 2 D 3 , is a 6-s-trans shaped bowl with the A-ring 30°above the plane of the C/D rings. In contrast, structure-function studies of rapid nongenomic actions of 1,25(OH) 2 D 3 and its analogues show that the VDR mem preferentially binds a ligand with a 6-s-cis shape (27) . This new ligand structure-function knowledge will allow chemists to synthesize analogues of 1␣,25(OH) 2 D 3 that are selective for either genomic or rapid responses, depending on the ligand's overall shape.
DETERMINATION OF VITAMIN D STATUS
As stated in the Introduction, the actions of 1␣,25(OH) 2 D 3 essential for good health depend on the vitamin D endocrine system. The operation of the vitamin D endocrine system to produce the steroid hormone 1␣,25(OH) 2 D 3 depends on the circulating concentration of 25(OH)D 3 ; this key metabolite is the substrate for the 25(OH)D 3 -1␣-hydroxylase enzyme that produces 1␣,25(OH) 2 D 3 . As is the case for any enzyme, the activity of the 1␣-hydroxylase depends on the absolute concentration of its substrate. The K m or substrate concentration of 25(OH)D 3 required for 50% maximal activity for the 1␣-hydroxylase is Ȃ100 nmol/L (11). As emphasized in Figure 2, Presented in Table 4 is a classification of circulating levels of 25(OH)D in relation to vitamin D nutritional status that was largely obtained from clinical studies relating to calcium homeostasis (intestinal calcium absorption, bone mineral density, parathyroid hormone concentrations, etc). In a large population of vitamin D-replete subjects, the normal range of 25(OH)D was found to be 25-137 nmol/L. But it was also noted that the lower limit of the normal range can vary among populations, ranging from as low as 20 up to 50 nmol/L (5). Undoubtedly, it will ultimately be essential to determine the normal 25(OH)D range in all ethnic groups and geographical populations of the world (at all latitudes to reflect differing UV exposures). I believe that a major goal for the vitamin D field is to agree on the "normal 25(OH)D serum levels" that support all 36 VDR-containing target organs in all the world's population groups.
FUNDAMENTALS OF VITAMIN D AND ITS ENDOCRINE SYSTEM FOR GOOD HEALTH
The purpose of the Adequate Intake recommendations for vitamin D put forth by the Food and Nutrition Board of the Institute of Medicine (5) in 1999 was to provide guidelines of vitamin D 3 intake to achieve normal serum levels of 25(OH)D. This was a very difficult goal to achieve, however, given that a quantitative relation of vitamin D's (ie, operation of the vitamin D endocrine system) contribution to good health was not clearly appreciated by 1997.
Tables 5 and 6 focus on the new biological actions of the steroid hormone 1␣,25(OH) 2 D 3 that must be carefully studied to appreciate their dependency on an adequate availability of vitamin D 3 to generate biological responses that are mediated by 1␣,25(OH) 2 D 3 to be fully compatible with proper health for each individual in the population. The 2 historical roles of vitamin D, namely stimulation of intestinal calcium absorption and increasing the mineral content and the remodeling of bone, are summarized in Table 5 . For each process (intestine or bone), historical reference citations are provided to create the foundation that vitamin D is crucial to bone mineral content and intestinal calcium absorption. Thus, between 1922 and 1924, the pioneers Mellanby (54), McCollum (55), and Goldblatt (56) made the separate bone-related discoveries, respectively, that 1) the treatment or prevention of rickets could be mediated by cod liver oil; 2) by feeding a new vitamin, termed vitamin D; or 3) by exposure of skin to UV irradiation. Then in 1937, Nicolayson (49) showed the potent actions of vitamin D 3 on stimulating intestinal calcium absorption in rats. Also included in Table 5 are comparable modern observations implicating the participation of the VDR and 1␣,25(OH) 2 D 3 in both intestinal calcium absorption and bone remodeling. It is these actions of 1␣,25(OH) 2 D 3 and its VDR that were largely addressed in 1999 by the Food and Nutrition Boards' guidelines for Adequate Intake of vitamin D 3 .
Summarized in Table 6 are the 5 physiologic arenas in which new biological actions of 1␣,25(OH) 2 D 3 and the VDR have been clearly documented and which have the capability of contributing to better health through improved vitamin D nutritional status. These include understanding at the molecular level the involvement of the VDR and 1␣,25(OH) 2 D 3 (in both genomic and rapid responses) in 1) the functioning of B and T lymphocytes, which constitutes the adaptive immune system; 2) the innate immune system; 3) secretion of insulin by the pancreatic ␤ cell; 4) the multifactorial functioning of the heart and blood pressure regulation; and 5) the multitude of activities of the brain. There are also multiple opportunities to address how the actions of the VDR and 1␣,25(OH) 2 D 3 can affect several diseases. These include prevention and treatment of several cancers (breast, colon, and prostate) through prodifferentiation, antiproliferation, or induction of apoptosis effects, hypertension (infant heart failure), immunomodulation (psoriasis, type 1 diabetes, inflammatory bowel disease, periodontal disease, multiple sclerosis, and possibly rheumatoid arthritis), and neuromuscular effects (muscle strength and better balance). Another critical goal is to understand the role of proper vitamin D nutrition and the molecular actions of the VDR with 1␣,25(OH) 2 D 3 for all the steps of fetal development.
The important points made in this presentation are summarized in Figure 7 . Researchers must understand the fundamentals of the vitamin D endocrine system, which include 1) vitamin D nutritional status (dietary intake and sunlight exposure), which define the circulating concentration of 25(OH)D 3 that is available to 2) the kidney functioning as an endocrine gland, which is complimented by 3) the paracrine 1␣-hydroxylase activities in 10 tissues to produce the steroid hormone 1␣,25(OH) 2 D 3 , which will 4) interact with the VDR in ͧ36 target tissues to generate optimal responsess in the calcium homeostasis system. Researchers must also understand the 5 new physiologic systems that collectively comprise the vitamin D endocrine system. 
Brain Yes Combined prenatal and chronic postnatal vitamin D deficiency in rats impairs prepulse inhibition of acoustic startle.
Heart function and blood pressure regulation Yes Research characterized heart size and blood pressure in the VDR knockout mouse.
Yes Hypocalcaemia and vitamin D deficiency is an important but preventable cause of life-threatening infant heart failure.
Yes 1␣,25(OH) 2 D 3 is a negative endocrine regulator of the renin-angiotensin system and blood pressure.
One can derive at least 3 important conclusions, one prediction, and one expectation from the discoveries made over the past 30 y pertaining to the wide tissue distribution of both the VDR and the extrarenal 25(OH)D 3 -1␣-hydroxylase
Conclusions

1)
Recent research has shown that vitamin D 3 's biological sphere of influence is much broader than researchers originally thought, as shown by the tissue distribution of the VDR, from mediating only calcium homeostasis (intestine, bone, kidney, and parathyroid) to functioning as a pluripotent hormone in 5 physiologic arenas in which researchers have clearly identified additional biological actions of 1␣,25(OH) 2 D 3 through the VDR. These physiologic arenas are the adaptive immune system, the innate immune system, insulin secretion by the pancreatic ␤ cell, multifactorial heart functioning and blood pressure regulation, and brain and fetal development.
2) Researchers have also expanded the parent vitamin D 3 's nutritional sphere of influence from a focus on bone health to include 5 additional physiologic systems.
3) The nutritional guidelines for vitamin D 3 intake must be carefully reevaluated to determine the adequate intake (balancing sunlight exposure with dietary intake) to achieve good health by involving all 36 target organs rather than just the first 4 target organs (intestine, kidney, bone, and parathyroid gland) that are considered for calcium homeostasis.
Corollary
Given that vitamin D 2 is significantly less biologically active in humans than is vitamin D 3 (7), its biological use as a dietary supplement in the United States should be discontinued and its use in a high-dose form [eg, 500 000 IU/mL of ergocalciferol (vitamin D 2 )] in clinical studies (73, 74) and as described in the Physicians Desk Reference (75) should be replaced by a new formulation of high-dose vitamin D 3 .
Prediction
Given the large expansion of the vitamin D endocrine system, the number of identified diseases or consequences of vitamin D deficiency or insufficiency will greatly increase to reflect the fact that the number of target organs for 1␣,25(OH) 2 D 3 has increased Ȃ9-fold since the discovery of the VDR in intestine, bone, kidney, and parathyroid tissues in the early 1970s.
Expectation or hope
More than ever, we need to increase the amount of research on vitamin D (ie, increase funding from government agencies and pharmaceutical companies) to meet the challenge of maximizing the knowledge of how to use vitamin D in the context of the vitamin D endocrine system to preserve or improve the health of everyone on the planet.
